{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T11:23:51Z","timestamp":1792409031241,"version":"4.4.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["arthroplastyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Arthroplasty"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.arth.2025.08.010","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T23:20:50Z","timestamp":1754954450000},"page":"S13-S22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"S1","title":["Preoperative Stand-Alone Intraosseous Cefuroxime in Total Knee Arthroplasty: A Randomized Trial Demonstrating Superior Tissue Concentrations and Improved Efficiency"],"prefix":"10.1016","volume":"40","author":[{"given":"Te","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runkai","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3910-0127","authenticated-orcid":false,"given":"Ming","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arth.2025.08.010_bib1","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.3390\/ijms24054320","article-title":"The challenge of periprosthetic joint infection diagnosis: from Current methods to emerging biomarkers","volume":"24","author":"Vrancianu","year":"2023","journal-title":"IJMS"},{"key":"10.1016\/j.arth.2025.08.010_bib2","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMra2203477","article-title":"Periprosthetic joint infection","volume":"388","author":"Patel","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arth.2025.08.010_bib3","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.arth.2022.01.057","article-title":"Higher tissue concentrations of Vancomycin achieved with low-dose intraosseous injection versus intravenous despite limited tourniquet duration in primary total knee arthroplasty: a randomized trial","volume":"37","author":"Spangehl","year":"2022","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.08.010_bib4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.arth.2013.09.030","article-title":"Perioperative antibiotics","volume":"29","author":"Hansen","year":"2014","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.08.010_bib5","doi-asserted-by":"crossref","first-page":"634","DOI":"10.3390\/antibiotics11050634","article-title":"Intraosseous regional administration of prophylactic antibiotics in total knee arthroplasty","volume":"11","author":"Wells","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.arth.2025.08.010_bib6","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1016\/j.arth.2021.03.035","article-title":"Incomplete administration of intravenous Vancomycin prophylaxis is common and associated with increased infectious complications after primary total hip and knee arthroplasty","volume":"36","author":"Feder","year":"2021","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.08.010_bib7","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1007\/s11999-011-2111-8","article-title":"Are bone and serum Cefazolin concentrations adequate for antimicrobial prophylaxis?","volume":"469","author":"Yamada","year":"2011","journal-title":"Clin Orthopaedics Relat Res"},{"key":"10.1016\/j.arth.2025.08.010_bib8","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s11999-012-2469-2","article-title":"Higher Cefazolin concentrations with intraosseous regional prophylaxis in TKA","volume":"471","author":"Young","year":"2013","journal-title":"Clin Orthopaedics Relat Res"},{"key":"10.1016\/j.arth.2025.08.010_bib9","doi-asserted-by":"crossref","first-page":"19S","DOI":"10.1378\/chest.115.suppl_1.19S","article-title":"Pharmacodynamic principles of antimicrobial therapy in the prevention of resistance","volume":"115","author":"Burgess","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.arth.2025.08.010_bib10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11999-013-3038-z","article-title":"The Mark Coventry award: higher tissue concentrations of vancomycin with low-dose intraosseous regional versus systemic prophylaxis in TKA: a randomized trial","volume":"472","author":"Young","year":"2014","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.arth.2025.08.010_bib11","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11999.0000000000000013","article-title":"The John N. Insall award: higher tissue concentrations of Vancomycin achieved with intraosseous regional prophylaxis in revision TKA: a randomized controlled trial","volume":"476","author":"Young","year":"2018","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.arth.2025.08.010_bib12","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.arth.2022.10.023","article-title":"Intraosseous regional administration of antibiotic prophylaxis for total knee arthroplasty: a systematic review","volume":"38","author":"Miltenberg","year":"2023","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.08.010_bib13","doi-asserted-by":"crossref","first-page":"S279","DOI":"10.1016\/j.arth.2018.09.012","article-title":"Hip and knee section, prevention, antimicrobials (Systemic): proceedings of international consensus on orthopedic infections","volume":"34","author":"Aboltins","year":"2019","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.08.010_bib14","doi-asserted-by":"crossref","DOI":"10.1007\/s00402-023-05108-1","article-title":"Higher cefazolin concentrations in synovial fluid with intraosseous regional prophylaxis in knee arthroplasty: a randomized controlled trial","author":"Zhang","year":"2023","journal-title":"Arch Orthop Trauma Surg"},{"key":"10.1016\/j.arth.2025.08.010_bib15","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1056\/NEJMoa2301401","article-title":"Trial of Vancomycin and Cefazolin as surgical prophylaxis in arthroplasty","volume":"389","author":"Peel","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arth.2025.08.010_bib16","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.arth.2022.01.019","article-title":"Preoperative prophylactic antibiotics in total hip and knee arthroplasty: what, when, and how","volume":"37","author":"Spangehl","year":"2022","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.08.010_bib17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11999-013-3038-z","article-title":"The mark Coventry award: higher tissue concentrations of Vancomycin with low-dose intraosseous regional versus systemic prophylaxis in TKA: a randomized trial","volume":"472","author":"Young","year":"2014","journal-title":"Clin Orthopaedics Relat Res"},{"key":"10.1016\/j.arth.2025.08.010_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.arth.2024.02.083","article-title":"Intraosseous versus intravenous Vancomycin in tourniquetless primary total knee arthroplasty: a randomized trial","author":"Wininger","year":"2024","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.08.010_bib19","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.arth.2023.04.028","article-title":"Otto aufranc award: intraosseous Vancomycin in total hip arthroplasty \u2014 superior tissue concentrations and improved efficiency","volume":"38","author":"Harper","year":"2023","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.08.010_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/516284","article-title":"Pharmacokinetic\/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men","volume":"26","author":"Craig","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.arth.2025.08.010_bib22","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1186\/s13054-020-03272-z","article-title":"Failure of target attainment of beta-lactam antibiotics in critically ill patients and associated risk factors: a two-center prospective study (EXPAT)","volume":"24","author":"Abdulla","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.arth.2025.08.010_bib23","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1093\/jac\/dkx001","article-title":"Determining \u03b2-lactam exposure threshold to suppress resistance development in Gram-negative bacteria","volume":"72","author":"Tam","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.arth.2025.08.010_bib24","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1080\/14787210.2017.1338139","article-title":"Optimizing \u03b2-lactams treatment in critically-ill patients using pharmacokinetics\/pharmacodynamics targets: are first conventional doses effective?","volume":"15","author":"Delattre","year":"2017","journal-title":"Expert Rev Anti-Infective Ther"},{"key":"10.1016\/j.arth.2025.08.010_bib25","doi-asserted-by":"crossref","DOI":"10.1177\/20420986251320414","article-title":"Navigating pharmacokinetic and pharmacodynamics challenges of \u03b2-lactam antibiotics in patients with low body weight: efficacy, toxicity, and dosage optimization","volume":"16","author":"Tseng","year":"2025","journal-title":"Ther Adv Drug Saf"},{"key":"10.1016\/j.arth.2025.08.010_bib26","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/jac\/dkab089","article-title":"Probability of pharmacological target attainment with flucloxacillin in Staphylococcus aureus bloodstream infection: a prospective cohort study of unbound plasma and individual MICs","volume":"76","author":"Moser","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.arth.2025.08.010_bib27","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ijantimicag.2010.06.008","article-title":"Therapeutic drug monitoring of \u03b2-lactams in critically ill patients: proof of concept","volume":"36","author":"Roberts","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.arth.2025.08.010_bib28","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3390\/antibiotics13090849","article-title":"Precision dosing of Meropenem in adults with normal renal function: insights from a population pharmacokinetic and Monte Carlo simulation study","volume":"13","author":"Kim","year":"2024","journal-title":"Antibiotics"},{"key":"10.1016\/j.arth.2025.08.010_bib29","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1093\/jac\/dkad296","article-title":"Real-world experience of therapeutic drug monitoring and PK\/PD achievement of ceftaroline administered by different infusion regimens in patients with confirmed infections caused by Gram-positive bacteria","volume":"78","author":"Fres\u00e1n","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.arth.2025.08.010_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.105754","article-title":"Double-dose cefuroxime concentrations in bone, synovial fluid of the knee joint and subcutaneous adipose tissue\u2013A randomised porcine microdialysis study","volume":"160","author":"J\u00f8rgensen","year":"2021","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.arth.2025.08.010_bib31","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.29702","article-title":"Tourniquet use and local tissue concentrations of Cefazolin during total knee arthroplasty: a randomized clinical trial","volume":"7","author":"Montreuil","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.arth.2025.08.010_bib32","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.arth.2018.03.013","article-title":"The AAHKS clinical research award: intraosseous regional prophylaxis provides higher tissue concentrations in high BMI patients in total knee arthroplasty: a randomized trial","volume":"33","author":"Chin","year":"2018","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.08.010_bib33","series-title":"Performance.Performance Standards for Antimicrobial Susceptibility Testing","year":"2024"},{"key":"10.1016\/j.arth.2025.08.010_bib34","article-title":"Tourniquet use for knee replacement surgery","volume":"12","author":"Ahmed","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.arth.2025.08.010_bib35","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13018-021-02898-1","article-title":"Impact of tourniquet during total knee arthroplasty when tranexamic acid was used: a meta-analysis of randomized controlled trials","volume":"17","author":"Sun","year":"2022","journal-title":"J Orthop Surg Res"},{"key":"10.1016\/j.arth.2025.08.010_bib36","doi-asserted-by":"crossref","first-page":"342","DOI":"10.2340\/17453674.2023.13793","article-title":"Use of a tourniquet is not associated with increased risk of venous thromboembolism after fast-track total knee arthroplasty: a prospective multicenter cohort study of 16,250 procedures","volume":"94","author":"Petersen","year":"2023","journal-title":"ActaO"},{"key":"10.1016\/j.arth.2025.08.010_bib37","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1111\/bcp.14121","article-title":"Physiologically based pharmacokinetic evaluation of cefuroxime in perioperative antibiotic prophylaxis","volume":"85","author":"Rimmler","year":"2019","journal-title":"Br J Clin Pharma"},{"key":"10.1016\/j.arth.2025.08.010_bib38","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1097\/CM9.0000000000002220","article-title":"Length of stay and inpatient charges of total knee arthroplasty in China: analysis of a national database","volume":"136","author":"Long","year":"2023","journal-title":"Chin Med J"},{"key":"10.1016\/j.arth.2025.08.010_bib39","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2165\/00003495-197917040-00001","article-title":"Cefuroxime: a review of its antibacterial activity, pharmacological properties and therapeutic use","volume":"17","author":"Brogden","year":"1979","journal-title":"Drugs"},{"key":"10.1016\/j.arth.2025.08.010_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.640740","article-title":"Minireview on novel anti-infectious treatment options and optimized drug regimens for sepsis","volume":"8","author":"Hites","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.arth.2025.08.010_bib41","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.j3418","article-title":"The antibiotic course has had its day","author":"Llewelyn","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.arth.2025.08.010_bib42","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1007\/s11999-014-4062-3","article-title":"Addition of Vancomycin to Cefazolin Prophylaxis is associated with acute kidney injury after primary joint arthroplasty","volume":"473","author":"Courtney","year":"2015","journal-title":"Clin Orthopaedics Relat Res"},{"key":"10.1016\/j.arth.2025.08.010_bib43","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.3390\/biomedicines9091128","article-title":"Serum inflammatory biomarkers in the diagnosis of periprosthetic joint infections","volume":"9","author":"Sigmund","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.arth.2025.08.010_bib44","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/cpt.2194","article-title":"Biomarker-Guided individualization of antibiotic therapy","volume":"110","author":"Aulin","year":"2021","journal-title":"Clin Pharma Ther"},{"key":"10.1016\/j.arth.2025.08.010_bib45","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1186\/s12891-022-05373-y","article-title":"Comparison of serum inflammatory indicators and radiographic results in MAKO robotic-assisted versus conventional total knee arthroplasty for knee osteoarthritis: a retrospective study of Chinese patients","volume":"23","author":"Xu","year":"2022","journal-title":"BMC Musculoskelet Disord"}],"container-title":["The Journal of Arthroplasty"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540325010150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540325010150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T20:20:19Z","timestamp":1762028419000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883540325010150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":44,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0883540325010150"],"URL":"https:\/\/doi.org\/10.1016\/j.arth.2025.08.010","relation":{},"ISSN":["0883-5403"],"issn-type":[{"value":"0883-5403","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preoperative Stand-Alone Intraosseous Cefuroxime in Total Knee Arthroplasty: A Randomized Trial Demonstrating Superior Tissue Concentrations and Improved Efficiency","name":"articletitle","label":"Article Title"},{"value":"The Journal of Arthroplasty","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arth.2025.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}